Synthesis of some hydroxynaphthazarins and their cardioprotective effects under ischemia-reperfusion in vivo

Bioorganic & Medicinal Chemistry Letters
1998.0

Abstract

A series of hydroxynaphthazarins has been synthesized. Some of them were found in in vivo experiments to be protectors of myocardium under ischemia-reperfusion and to reduce the infarction zone by 50% without any adverse effect. All compounds exhibit a moderate or small toxicity and are active in low doses.

Knowledge Graph

Similar Paper

Synthesis of some hydroxynaphthazarins and their cardioprotective effects under ischemia-reperfusion in vivo
Bioorganic & Medicinal Chemistry Letters 1998.0
Discovery of β-Carboline Derivatives as a Highly Potent Cardioprotectant against Myocardial Ischemia-Reperfusion Injury
Journal of Medicinal Chemistry 2021.0
Design and Synthesis of Novel Pyridoxine 5‘-Phosphonates as Potential Antiischemic Agents
Journal of Medicinal Chemistry 2003.0
Na<sup>+</sup> Currents in Cardioprotection: Better to Be Late
Journal of Medicinal Chemistry 2009.0
Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities
European Journal of Medicinal Chemistry 2022.0
Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat
European Journal of Medicinal Chemistry 2020.0
Synthesis and Pharmacological Evaluation of Novel Adenine–Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents
Journal of Medicinal Chemistry 2016.0
Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agent
Bioorganic &amp; Medicinal Chemistry 2012.0
Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury
ACS Medicinal Chemistry Letters 2018.0
Development of Novel Antiatherogenic Biaryls: Design, Synthesis, and Reactivity
Journal of Medicinal Chemistry 2008.0